Cleared Traditional

K222671 - DeltaScan Patch

K222671 is an FDA 510(k) clearance for DeltaScan Patch, manufactured by Prolira B.V.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K222671 · Prolira B.V. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
149d
Days
Class 2
Risk

K222671 is an FDA 510(k) clearance for the DeltaScan Patch. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Prolira B.V. (Utrecht, NL). The FDA issued a Cleared decision on February 2, 2023 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Prolira B.V. devices

FDA 510(k) Submission Details - K222671

510(k) Number K222671 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2022
Decision Date February 02, 2023
Days to Decision 149 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 148d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Corolla Clin/Reg Consulting
Paul J Manberg

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 194
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K222671.
Starly pad
K221589 · Shenzhen Xingyuanli Technology Co., Ltd. · Mar 2023
Ceribell Instant EEG Headcap
K223086 · Ceribell, Inc. · Mar 2023
Motive™ Electrode
K230533 · Cymedica Orthopedics, Inc. · Mar 2023
Garment Electrodes
K222863 · Tone-A-Matic International, Inc. · Feb 2023
Disposable Non-invasive EEG Sensor
K220448 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Jan 2023
Self-adhesive Electrode
K222252 · Shenzhen Roundwhale Technology Co. , Ltd. · Jan 2023